期刊论文详细信息
BMC Pediatrics
Safety and efficacy of a 100 % dimethicone pediculocide in school-age children
Lawrence Rosen1  Ji Meng Loh3  Jeffrey R. Boscamp2  Erin Speiser Ihde1 
[1] The Deirdre Imus Environmental Health Center®, Hackensack University Medical Center, 30 Prospect Ave, Hackensack 07601, NJ, USA;Hackensack University Medical Center, The Joseph M. Sanzari Children’s Hospital, 30 Prospect Avenue, Hackensack 07601, NJ, USA;Dept. of Mathematical Sciences, NJ Institute of Technology - University Heights, Newark 07102, NJ, USA
关键词: Children;    School;    Infestation;    Dimethicone;    Head lice;    Pediatrics;    Pediculus humanus capitis;    Pediculosis;   
Others  :  1217905
DOI  :  10.1186/s12887-015-0381-0
 received in 2014-08-25, accepted in 2015-05-18,  发布年份 2015
PDF
【 摘 要 】

Background

Head lice most commonly affect children, ages 3 to 11. Concerns exist about the safety and efficacy of pesticide-based treatments. Published studies suggest dimethicone is a potentially safe and effective non-toxic treatment, but have not evaluated 100 % dimethicone in a pediatric population. The objectives were to evaluate the efficacy and safety of 100 % dimethicone for the treatment of head lice in children, monitored by school nurses.

Methods

This was a multi-site, open-label study of a 100 % dimethicone gel for the treatment of head lice in a pediatric population. Children (ages 3–12) suspected of infestation with head lice were evaluated by school nurses at six schools and daycare programs in New York and New Jersey. Inclusion criteria were presence of at least three live lice, or one live louse and 10 viable eggs (eggs found within 1.27 cm of the scalp) and no use of any head lice treatment within four weeks of enrollment. Counts of live lice and viable eggs found in 58 subjects were tracked at baseline (Day 0) and on Day 1, Day 7, and Day 14 after treatment.

Results

After 1 day of treatment with 100 % dimethicone, 98.30 % of subjects were free of live lice and 55.20 % were free of viable eggs. On day 14, 96.50 % were still free of live lice, and 80.70 % were free of viable eggs. All subjects were monitored by the school nurse at baseline and throughout the study period for adverse effects, including scalp erythema, excoriation, flaking and edema. There was one adverse event of skin irritation lasting 10 min, and no serious adverse events reported. Overall, scalp conditions improved from the baseline: 10 subjects (17.5 %) reported mild to moderate scalp erythema on day 1, compared with only one subject (1.7 %) on day 14; 8 subjects (14.3 %) reported mild scalp excoriation on day 1, with none reporting on day 14.

Conclusions

100 % dimethicone was found to be a safe and highly effective treatment for pediatric head lice. Because dimethicone avoids pesticide exposure and resistance issues, dimethicone should be considered as a first-line treatment for head lice.

Trial Registration

NCT02213055 Date of registration: August 8, 2014

Standards of reporting

The CONSORT 2010 Checklist was consulted during the review of this manuscript. Please note that sections pertaining specifically to randomized controlled trials (RCT’s) were not applicable.

【 授权许可】

   
2015 Ihde et al.

【 预 览 】
附件列表
Files Size Format View
20150709021726606.pdf 502KB PDF download
Fig. 2. 63KB Image download
Fig. 1. 25KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】
  • [1]Centers for Disease Control & Prevention Head Lice FAQs – Who is at Risk for Getting Head Lice? http://www. cdc.gov/parasites/lice/head/gen_info/faqs.html webcite
  • [2]Frankowski BL. Clinical Report: Head Lice. Pediatrics. 2010; 126(2):392-403.
  • [3]Pickering LK. Pediculosis Capitis (Head Lice). In: Red Book: 2012 Report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL; 2012: p.543-546.
  • [4]Carozza SE, Li B, Elgethun K, Whitworth R. Risk of Childhood Cancers Associated with Residence in Agriculturally Intense Areas in the United States. Environ Health Perspect. 2008; 116(4):559-65.
  • [5]Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S. In Utero Pesticide Exposure and Leukemia in Brazilian Children < 2 Years of Age. Environ Health Perspect. 2013; 121(2):269-75.
  • [6]Naeher LP, Barr DB, Rithmire N, Edwards J, Holmes AK, Needham LL et al.. Pesticide Exposure Resulting from Treatment of Lice Infestation in School-Aged Children in Georgia. Environ Int. 2009; 35(2):358-62.
  • [7]Durand R, Bouvresse S, Berdjane Z, Izri A, Chosidow O, Clark JM. Insecticide resistance in head lice: clinical, parasitological and genetic aspects. Clin Microbiol Infect. 2012; 18(4):338-44.
  • [8]Clark JM. Determination, mechanism and monitoring of knockdown resistance in permethrin-resistant human head lice, Pediculus humanus capitis. J Asia Pac Entomol. 2009; 12(1):1-7.
  • [9]Bouvresse S, Berdjane Z, Durand R, Bouscaillou J, Izri A, Chosidow O. Permethrin and malathion resistance in head lice: results of ex vivo and molecular assays. J Am Acad Dermatol. 2012; 67(6):1143-50.
  • [10]Chosidow O, Chastang C, Brue C, Bouvet E, Izri M, Monteny N. Controlled study of malathion and d-phenothrin lotions for Pediculus humanus var capitis-infested schoolchildren. Lancet. 1994; 344(8939–8940):1724-7.
  • [11]Rupes V, Moravec J, Chmela J, Ledvinka J, Zelenková J. A resistance of head lice (Pediculus capitis) to permethrin in Czech Republic. Cent Eur J Public Health. 1995; 3(1):30-2.
  • [12]Mumcuoglu KY, Hemingway J, Miller J, Ioffe-Uspensky I, Klaus S, Ben-Ishai F et al.. Permethrin resistance in the head louse Pediculus capitis from Israel. Med Vet Entomol. 1995; 9(4):427-32.
  • [13]Burgess IF. The mode of action of dimeticone 4 % lotion against head lice. Pediculus capitis BMC Pharmacol. 2009; 9:3. BioMed Central Full Text
  • [14]Burgess IF, Brunton ER, Burgess NA. Single application of 4 % dimeticone liquid gel versus two applications of 1 % permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial. BMC Dermatol. 2013; 13:5. BioMed Central Full Text
  • [15]Heukelbach J, Pilger D, Oliveira FA, Khakban A, Ariza L, Feldmeier H. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis. 2008; 8:115. BioMed Central Full Text
  • [16]Burgess IF, Lee PN, Matlock G: Randomised, controlled, assessor blind trial comparing 4 % dimeticone lotion with 0.5 % malathion liquid for head louse infestation. PLoS One 2007,2(11):e1127.
  • [17]Burgess IF. Head Lice. Clin Evid. 2011; 05:1703.
  • [18]Heukelbach J, Sonnberg S, Becher H, Melo I, Speare R, Oliveira FA. Ovicidal efficacy of high concentration dimeticone: a new era of head lice treatment. J Am Acad Dermatol. 2011; 64(4):e61-2.
  • [19]Burgess IF, Burgess NA. Dimeticone 4 % liquid gel found to kill all lice and eggs with a single 15 minute application. BMC Res Notes. 2011; 4:15. BioMed Central Full Text
  • [20]Izri A, Uzzan B, Maigret M, Gordon MS, Bouges-Michel C. Clinical efficacy and safety in head lice infection by Pediculus humanis capitis De Geer (Anoplura: Pediculidae) of a capillary spray containing a silicon-oil complex. Parasite. 2010; 17(4):329-35.
  • [21]Kurt O, Balcioğlu IC, Burgess IF, Limoncu ME, Girginkardeşler N, Tabak T et al.. Treatment of head lice with dimeticone 4 % lotion: comparison of two formulations in a randomised controlled trial in rural Turkey. BMC Public Health. 2009; 9:441. BioMed Central Full Text
  • [22]Heukelbach J, Pilger D, Oliveira FA, Khakban A, Ariza L, Feldmeier H. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis. 2008; 8:115. BioMed Central Full Text
  • [23]Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4 % dimeticone lotion: randomised controlled equivalence trial. BMJ. 2005; 330(7505):1423.
  • [24]Heukelbach J, Asenov A, Liesenfeld O, Mirmohammadsadegh A, Oliveira FA. A new two-phase dimeticone pediculicide shows high efficacy in a comparative bioassay. BMC Dermatol. 2009; 9:12. BioMed Central Full Text
  • [25]Gallardo A, Mougabure-Cueto G, Vassena C, Picollo MI, Toloza AC. Comparative efficacy of new commercial pediculicides against adults and eggs of Pediculus humanus capitis (head lice). Parasitol Res. 2012; 110(5):1601-6.
  • [26]Strycharz JP, Lao AR, Alves AM, Clark JM. Ovicidal response of NYDA formulations on the human head louse (Anoplura: Pediculidae) using a hair tuft bioassay. J Med Entomol. 2012; 49(2):336-42.
  • [27]Speare R. A single application of dimeticone is superior to two applications of permethrin in ridding head lice. J Pediatr. 2013; 163(5):1531-2.
  • [28]Committee on Infectious Diseases, American Academy of Pediatrics. Pickering LK, ed. American Academy of Pediatrics Red Book®: 2012 Report of the Committee on Infectious Diseases - Pediculosis Capitis. 2012; 29th Ed:543-46.
  • [29]Devore, CD, Schutze, GE and the Council on School Health and Committee on Infectious Diseases. American Academy of Pediatrics Clinical Report: Head Lice. Pediatrics. 2015; 135:(5) e1355-e1365; published ahead of print April 27, 2015.
  • [30]Getting Rid of Lice - LiceMD® Pesticide Free Treatment Instructions. http://www. licemd.com/getting-rid-of-lice.php webcite
  文献评价指标  
  下载次数:36次 浏览次数:12次